# Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis

> **NCT02297867** · PHASE1 · COMPLETED · sponsor: **Gwo Xi Stem Cell Applied Technology Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** ADSCs

## Key facts

- **NCT ID:** NCT02297867
- **Lead sponsor:** Gwo Xi Stem Cell Applied Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-13
- **Primary completion:** 2017-12-18
- **Final completion:** 2018-03-27
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02297867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02297867, "Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02297867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*